Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Millions of individuals with coronary artery, or valvular heart disease have been given a new chance at life by heart surgery, but the potential for neurological injury is a great risk .Neural complications - including neurocognitive dysfunction and ischemic complications are complications of cardiac surgery that can restrict the improved quality of life.
Propofol is one of the most popular agents used for induction of anesthesia. propofol reduces cerebral blood flow but maintains coupling with cerebral metabolic rate for oxygen and decreases intracranial pressure, allowing optimal intraoperative conditions.
Ketamine is a non-competitive antagonist of NMDA receptors that has well documented neuroprotective effects against ischemic brain injury and glutamate-induced brain injury. ketamine has neuroprotective effects against oxygen-glucose deprivation injury
The aim of the study is to evaluate neuroprotective effect of mixture of propofol and ketamine (ketofol) as compared to propofol after open heart surgery.
Induction;
Catheterization:
Position of the catheter will be confirmed by antero-posterior and lateral neck C-arm x-ray to verify the correct placement of the catheter tip in the will be sutured to the skin and dressed with sterile gauze
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| propofol group | Experimental |
|
|
| ketofol group | Active Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ketofol (propofol to ketamine ratio 1:1) | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cerebral oxygenation | Cerebral oxygenation as indicated by calculation of:
| from start of surgery and for 24 hours postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| blood pressure measurement | measurement of invasive blood pressure | from start of surgery and for 24 hours postoperative |
Not provided
Inclusion Criteria:Age between 30 and 70 years of either sex.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| mona a hashish, M.D | professor of anesthesia | Study Chair |
| ahmed m elshamy, master | assistant lecturer of anesthesia | Principal Investigator |
| ghada f amer, M.D | associate professor of anesthesia | Principal Investigator |
| magdy m attalaha, M.D | professor of anethesia | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015742 | Propofol |
| ID | Term |
|---|---|
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
Not provided
Not provided
2 groups of patients subjected to open heart surgery : Propofol group: Propofol, dose 0.5-2 mg/kg.
Not provided
Not provided
- Double blind study
| propofol | Drug | Propofol infusion, 25-150 mcg/kg/min.
|
|
|
| D006838 |
| Hydrocarbons |
| D009930 | Organic Chemicals |